Gastroenterology
fact that chronic diseases fill the capacity that is given to them, while the needs of such conditions continue to expand. Services need to think about getting the right clinician to see the right patient, at the right time, to ensure that the system is as efficient as possible – this requires more clinical coordination of the pathways. Looking to the future, I believe it will be beneficial to have more apps for remote monitoring – supporting appropriate patient cohorts in self-management, overseen by clinicians.
It would be hugely beneficial for the
government and NHS England to prioritise IBD and other bowel conditions by introducing specific targets and milestones, like those that currently exist for cancer and cardiovascular disease, to support the adoption of best practice care across the patient pathway. Balancing this, it is also important for individual hospitals to know the patient population they serve and tailor their service to meet the needs of those patients.
CSJ
* This article was initiated and written by Takeda UK in collaboration with Professor Ailsa Hart.
References 1 IBD UK, Crohn’s and Colitis Care in the UK: The Hidden Cost and a Vision for Change, April 2021. Last accessed July 2023. Available at:
https://ibduk.org/reports/crohns-and- colitis-care-in-the-uk-the-hidden-cost-and- a-vision-for-change
2 IBD UK, IBD Standards. Last accessed July 2023. Available at:
https://ibduk.org/ibd- standards
The Takeda report
The Takeda report ‘Levelling up care for people living with Inflammatory Bowel Disease (IBD): A spotlight on service exemplars’ details the best practice standard of care at all points along the IBD patient pathway, and forms part of Takeda’s 500,000 Reasons Why campaign. The report is designed to draw attention to some of the real-life examples of best practice at all points along the IBD pathway from across the UK. The report forms a significant part of Takeda’s effort to support the system to optimise their services and improve patient outcomes. To find out more about the campaign, visit: https://www.takeda. com/en-gb/what-we-do/delivering-for- patients-with-gi-conditions
Enabling informed clinical decision
making and improved patient outcomes with our integrated sepsis solution
3 Kapasi R., et al, Consensus standards of healthcare for adults and children with inflammatory bowel disease in the UK,
About the author
Ailsa Hart is a Consultant Gastroenterologist at St Mark’s Hospital and Dean of St Mark’s Hospital Academic Institute, London, UK. In 2016, she achieved academic promotion at Imperial College London, UK, and is now Professor of Practice. She is also Honorary Skou Professor at the University of Aarhus in Denmark. She studied medicine at Oxford University and was awarded a First-Class Honours Degree. She achieved her PhD with Imperial College London, funded by a Wellcome Trust Fellowship. She has mentored
Frontline Gastroenterology 2020;11:178–187.
https://fg.bmj.com/content/flgastro/ early/2019/07/19/flgastro-2019-101260.full.pdf
and trained many gastroenterologists, who are now clinical investigators engaged in IBD research nationally and internationally. Together with many of them, she has published two books and over 300 papers, reviews and book chapters.
T.H.I.N.K T.A.T
THINK SEPSIS
T
GET TIME ON YOUR SIDE
E
January 2024 I
www.clinicalservicesjournal.com 59
E
N
T
I
C
I
S
T
M
E
H
E
E
S
I
S
S
E
O
O
E
T
F
H
T
R
N
P
I
S
E
S
M
F
A
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
